Patents by Inventor Stéphanie Millecamps-Navarro

Stéphanie Millecamps-Navarro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neuronal gene transfer of adenovirus and herpes virus vectors
    Patent number: 7341718
    Abstract: The present invention is related to compositions and methods for the delivery of nucleic acids to neurons in a mammal, and uses thereof. The present invention specifically discloses the use of compounds that cause synaptic nerve sprouting to increase neuron retrograde transport of a vector or a product (a polypeptide or a nucleic acid for example) in a mammal. The invention is also based on the use of a compound that interacts with synaptosomal associated proteins to increase neuron retrograde transport of a vector or a product such as one cited above in a mammal. The invention also relates to a product comprising a viral vector comprising a transgene and a compound that causes synaptic nerve sprouting, for sequential use for delivering said transgene to neurons by retrograde transport and its uses for the preparation of a composition used as a treatment in several neurological disorders.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: March 11, 2008
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Stéphanie Millecamps-Navarro, Martine Barkats, Jacques Mallet
  • Neuronal gene transfer
    Publication number: 20040131593
    Abstract: The present invention is related to compositions and methods for the delivery of nucleic acids to neurons in a mammal, and uses thereof. The present invention specifically discloses the use of compounds that cause synaptic nerve sprouting to increase neuron retrograde transport of a vector or a product (a polypeptide or a nucleic acid for example) in a mammal. The invention is also based on the use of a compound that interacts with synaptosomal associated proteins to increase neuron retrograde transport of a vector or a product such as one cited above in a mammal. The invention also relates to a product comprising a viral vector comprising a transgene and a compound that causes synaptic nerve sprouting, for sequential use for delivering said transgene to neurons by retrograde transport and its uses for the preparation of a composition used as a treatment in several neurological disorders.
    Type: Application
    Filed: February 24, 2004
    Publication date: July 8, 2004
    Inventors: Stephanie Millecamps-Navarro, Martine Barkats, Jacques Mallet